Skip to main content
Next generation of value-added ingredients

Request a Sample
Account
Business account
Order
0 items
Request a Sample
About NexaGens Quality & Compliance Knowledge Hub Contact

About NexaGens

Netherlands-based B2B ingredient company

NexaGens B.V. is a Netherlands-based B2B developer and supplier of value-added ingredients, established in 2026. NexaGens develops, specifies, commercialises and supplies technology-led ingredient formats for professional formulation.

Technical capability with defined responsibilities

NexaGens is supported by Netherlands-based R&D and quality-control resources within the Nova Techs group, including technical and formulation expertise at PhD level, together with qualified manufacturing, analytical and regulatory partners.

What NexaGens controls — and what partners execute

Responsibilities are separated so customers can see how product requirements, technical evidence, manufacture and commercial release are governed.

Development and specification ownership

NexaGens manages target product profiles, technology and material selection, product specifications, test requirements, acceptance criteria, change control and product lifecycle oversight.

Qualified partner execution

Pilot and commercial manufacture, process scale-up, analytical testing and specialist characterisation are performed by qualified product-specific manufacturing and laboratory partners.

Documented quality oversight

A documented, risk-based framework covers partner qualification, specification approval, document and evidence review, traceability, change control, deviations, complaints and corrective actions.

Commercial batch release

After manufacturer and laboratory review, NexaGens makes the final commercial batch-release decision against the approved product specification for products it supplies.

Specification-to-supply journey

A clear path from requirement to commercial supply

Product maturity, sample and document availability, MOQ, lead time, packaging and logistics are confirmed for the individual product and quotation. An NDA can be used where confidential information will be exchanged.

  1. Define the requirement

    Provide the product or formulation requirement, intended application and market, expected quantity and document needs.

  2. Review fit and status

    NexaGens reviews technical fit, regulatory considerations and product maturity, and puts an NDA in place where confidential information will be exchanged.

  3. Confirm documents and evaluation

    The applicable specification, current document set and sample options are confirmed. Where appropriate, the customer evaluates a product-specific sample.

  4. Confirm commercial terms

    NexaGens confirms availability, MOQ, lead time, testing and release requirements, packaging and logistics, then issues a product-specific quotation.

  5. Review, release and supply

    After order acceptance, product is produced or allocated and tested by the applicable partners. NexaGens completes the final commercial-release review and arranges dispatch with the agreed documents.